Table 1 Demographic and prior-drug use information of study participants
Total N(%) | Malea n(%) | Femalea n(%) | p-value | |
|---|---|---|---|---|
Age groupb | 0.233 | |||
18–24 years | 384(29.0) | 138(26.2) | 246(30.6) | |
25–31 years | 553(41.7) | 234(44.0) | 319(39.7) | |
32–38 years | 257(19.3) | 98(18.6) | 159(19.8) | |
39–45 years | 96(7.2) | 37(7.0) | 59(7.3) | |
46 years and above | 41(3.1) | 20(3.8) | 21(2.6) | |
Educational levelc | 0.283 | |||
No education | 50(3.8) | 18(3.4) | 32(4.0) | |
Primary/Junior High School | 238(18.0) | 85(16.1) | 153(19.2) | |
Secondary and above | 1038(78.3) | 425(80.5) | 613(76.8) | |
Antimicrobial use within 2 weeks prior to clinic presentation | < 0.001 | |||
Yes | 383(28.4) | 201(37.6) | 182(22.6) | |
No | 966(71.6) | 333(62.4) | 623(77.4) |